Carnegie acted as joint bookrunner in the SEK 500 million issuance of senior secured social bonds by Orexo.
Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs.